| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/NIMG.1999.0431 |
| P698 | PubMed publication ID | 10329294 |
| P50 | author | Roger N. Gunn | Q41909429 |
| P2093 | author name string | Myers R | |
| Meyer JH | |||
| Grasby PM | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 545-553 | |
| P577 | publication date | 1999-05-01 | |
| P1433 | published in | NeuroImage | Q1981225 |
| P1476 | title | Assessment of spatial normalization of PET ligand images using ligand-specific templates | |
| P478 | volume | 9 |
| Q51036179 | A [11C]Ro15 4513 PET study suggests that alcohol dependence in man is associated with reduced α5 benzodiazepine receptors in limbic regions. |
| Q45052989 | A positron emission tomography study of the 5-HT1A receptor in schizophrenia and during clozapine treatment |
| Q30619534 | A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophrenia |
| Q64110761 | A whole-body FDG PET/MR atlas for multiparametric voxel-based analysis |
| Q34054242 | Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study |
| Q95269974 | Amyloid accumulation in Down syndrome measured with amyloid load |
| Q31151770 | Assessment of parameter settings for SPM5 spatial normalization of structural MRI data: application to type 2 diabetes |
| Q48497018 | Assessment of spatial normalization of whole-brain magnetic resonance images in children |
| Q48920998 | Automated striatal uptake analysis of ¹⁸F-FDOPA PET images applied to Parkinson's disease patients |
| Q51811099 | Cerebral acetylcholinesterase activity is not decreased in MS patients with cognitive impairment. |
| Q44376668 | Cerebral serotonin transporter asymmetry in females, males and male-to-female transsexuals measured by PET in vivo |
| Q42473091 | Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia |
| Q46686141 | Cognitive deficits and striato-frontal dopamine release in Parkinson's disease. |
| Q41896612 | Comparison of PET template-based and MRI-based image processing in the quantitative analysis of C11-raclopride PET. |
| Q48551873 | Comparison of spatial normalization procedures and their impact on functional maps |
| Q37127709 | Creation and validation of an I-123 FP-CIT template for statistical image analysis using high-resolution SPECT for parkinsonian patients |
| Q46923228 | Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. |
| Q52991578 | Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study. |
| Q43807805 | Does human presynaptic striatal dopamine function predict social conformity? |
| Q46969767 | Dopamine D2 receptor occupancy levels of acute sulpiride challenges that produce working memory and learning impairments in healthy volunteers |
| Q41845653 | Dopamine Transporter Correlates and Occupancy by Modafinil in Cocaine-Dependent Patients: A Controlled Study With High-Resolution PET and [(11)C]-PE2I |
| Q60644555 | Drug action at the 5-HT1A receptor in vivo: autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-11C]WAY-100635 |
| Q35178976 | Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging |
| Q40247358 | Evaluation of MRI and cannabinoid type 1 receptor PET templates constructed using DARTEL for spatial normalization of rat brains |
| Q42328545 | Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases |
| Q40135278 | Evaluation of software tools for automated identification of neuroanatomical structures in quantitative β-amyloid PET imaging to diagnose Alzheimer's disease |
| Q34314230 | Expectation of caffeine induces dopaminergic responses in humans |
| Q35683827 | Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image |
| Q48405092 | Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients |
| Q48584250 | IBZM tool: a fully automated expert system for the evaluation of IBZM SPECT studies |
| Q38132714 | Imaging the role of GABA in movement disorders |
| Q57089038 | Implementation and application of a brain template for multiple volumes of interest |
| Q52278437 | Increased left posterior parietal-temporal cortex activation after D-fenfluramine in women with panic disorder. |
| Q48421523 | Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving |
| Q44355507 | Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders |
| Q44525573 | Influence of the normalization template on the outcome of statistical parametric mapping of PET scans. |
| Q33388271 | Kinetic modelling of [11C]flumazenil using data-driven methods |
| Q60620013 | Mapas de estadísticos paramétricos (SPM) en medicina nuclear |
| Q43296876 | Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study |
| Q44340060 | Measurement of central mu-opioid receptor binding in vivo with PET and [11C]carfentanil: a test-retest study in healthy subjects |
| Q46816955 | Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test-retest reproducibility |
| Q36966673 | Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. |
| Q30418000 | Nature or nurture? Determining the heritability of human striatal dopamine function: an [18F]-DOPA PET study |
| Q39155830 | Neurotransmitters behind pain relief with transcranial magnetic stimulation - positron emission tomography evidence for release of endogenous opioids |
| Q33632112 | Optimized data preprocessing for multivariate analysis applied to 99mTc-ECD SPECT data sets of Alzheimer's patients and asymptomatic controls |
| Q33925457 | PET imaging of neurokinin-1 receptors with [(18)F]SPA-RQ in human subjects: assessment of reference tissue models and their test-retest reproducibility |
| Q48162000 | Perfusion-like template and standardized normalization-based brain image analysis using 18F-florbetapir (AV-45/Amyvid) PET. |
| Q44813014 | Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. |
| Q49022290 | Polymodal motion processing in posterior parietal and premotor cortex: a human fMRI study strongly implies equivalencies between humans and monkeys |
| Q44400030 | Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study. |
| Q38511223 | Quantification analysis of 123I-IPT single photon emission computed tomography uptake in the striatum of parkinsonism with the standard magnetic resonance template |
| Q59845518 | Quantitative analysis of [carbonyl-11C]WAY-100635 PET studies |
| Q58099045 | Quantitative study of F-(+)DTBZ image: comparison of PET template-based and MRI based image analysis |
| Q35024111 | Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology |
| Q33460473 | Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data |
| Q48557699 | Statistical neuroanatomy of the human inferior frontal gyrus and probabilistic atlas in a standard stereotaxic space |
| Q38972564 | Striatal and Extrastriatal Dopamine Transporter Availability in Schizophrenia and Its Clinical Correlates: A Voxel-Based and High-Resolution PET Study. |
| Q48966323 | Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study |
| Q46771287 | Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET. |
| Q46832195 | Task-related interaction between basal ganglia and cortical dopamine release. |
| Q35936402 | The Role of the Serotonergic System in REM Sleep Behavior Disorder |
| Q48424693 | The catechol-O-methyltransferase Val(158)Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson's disease: a PET study |
| Q37500893 | The dopaminergic basis of human behaviors: A review of molecular imaging studies |
| Q43227930 | The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder |
| Q46548932 | The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635. |
| Q47744319 | Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe |
| Q42359354 | Volume of Interest Analysis of Spatially Normalized PRESTO Imaging to Differentiate between Parkinson Disease and Atypical Parkinsonian Syndrome |
Search more.